參考文獻(xiàn)/References:
[1] Kundu S.Central venous disease in hemodialysis patients: prevalence, etiology and treatment[J]. J Vasc Access, 2010, 11(1):1-7.[2] Cuthbert G A, Lo Z J, Kwan J, et al.Outcomes of central venoplasty in haemodialysis patients [J]. Ann Vasc Dis, 2018, 11(3):292-297.[3] 中國醫(yī)院協(xié)會血液凈化中心管理分會血液凈化通路學(xué)組.中國血液透析用血管通路專家共識(第2版)[J].中國血液凈化,2019,18(6):365-381. [4] 朱紅平,趙秋燕,崔天蕾,等.經(jīng)皮血管球囊擴(kuò)張成形術(shù)在中心靜脈狹窄患者再置管中的應(yīng)用[J].四川大學(xué)學(xué)報:醫(yī)學(xué)版,2015,46(2):315-317.[5] Ginsburg M, Lorenz J M, Zivin S P,et al.A practical review of the use of stents for the maintenance of hemodialysis access [J]. Semin Intervent Radiol, 2015, 32(2):217-224.[6] Hongsakul K, Leelarujijaroen P, Boonsrirat U.Outcome of central vein occlusion recanalization in hemodialysis patients and predictors for success:a retrospective study [J]. J Belg Soc Radiol,2020, 104(1): 20, 1-8.[7] Wang J, Nguyen T A, Chin A I,et al.Treatment of tunneled dialysis catheter malfunction: revision versus exchange [J]. J Vasc Access, 2016, 17(4):328-332.
相似文獻(xiàn)/References:
[1]張秀安.非基因重組促細(xì)胞生成素依賴的血液透析影響因素分析[J].福建醫(yī)藥雜志,2022,44(05):18.
ZHANG Xiu'an.Analysis of influencing factors of non-gene recombinant erythropoietin-dependent hemodialysis[J].FUJIAN MEDICAL JOURNAL,2022,44(02):18.